Lenskart vs Titan: manufacturing-led scale meets optometry strength in India's $9.2bn eyewear race

Post-listing comparison pits Lenskart's vertically integrated, store-expansion model (203 net new stores, 431 cities, 69.2% Q2 product margin) against Titan's optometry and fitting-lab depth (871 EyeCare stores, 9.3M eye tests in H1 FY26). Lenskart Q2 FY26 revenue Rs 2,146.6 crore, up 24% YoY; stock down 2.23% last month vs Titan +0.99%.

— FiledSat, 4 Jul, 2026, 05:35 IST·First seen Sat, 4 Jul, 2026, 05:34 IST·Source Financial Express · BrandWagon

What happened

Post-listing comparison of Lenskart and Titan Eyewear in India's ~$9.2bn eyewear market, contrasting Lenskart's manufacturing-led model and store expansion

Key facts

  • listed at Rs 390
  • issue price Rs 402
  • down 2.23% last month
  • Titan +0.99% last month, +10.85% last year
  • $9.2 billion Indian eyewear market
  • Rs 30,000 crore market (Titan estimate)
  • Titan share under 12%
  • 9.3 million eye tests H1 FY26
  • 46% first-time users
  • 203 net new stores
  • 431 cities
  • 871 Titan EyeCare stores
  • next-day delivery in 58 cities
  • Q2 product margin 69.2%
  • 35%-40% cost advantage
  • 4 million frames H1
  • Q2 FY26 revenue Rs 2,146.6 crore, up 24% YoY

What to watch

  • Lenskart Q3 FY26 same-store-sales growth vs new-store dilution
  • Product margin trajectory (holding >65% vs erosion)
  • Post-IPO lock-up expiry dates and promoter/PE selling
  • Titan EyeCare segment revenue and eye-test volume growth in H2 FY26
  • Store-addition pace and payback period disclosures
  • Any discounting war signals or import-duty/component cost changes
  • Lenskart accelerates optometry/eye-test capability to close Titan's diagnostic gap and lift store footfall conversion
  • Titan expands value-tier EyeCare formats and B2C online to counter Lenskart on price and reach
  • Both invest in in-house lens manufacturing/fitting labs to defend product margins
  • Lenskart deepens international (SEA/Gulf) expansion to justify growth premium
  • Competitive marketing spend rises on progressive lenses and subscription/insurance-linked eyecare bundles